GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Suven Life Sciences Ltd

Suven Life Sciences Board Approves Rs. 248.83 Cr Preferential Allotment, New Subsidiary

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 08 Jul 2026, 04:52 PM IST  ·  BSE ID: 656b6123-2862-4dde-a545-9454db58398c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company successfully raised over Rs. 248 Crore by issuing new shares to investors at a set price.
🤖 AI Summary
  • Suven Life Sciences raised Rs. 248.83 Crore via preferential allotment of 1.85 Cr shares.
  • 1,85,70,133 equity shares allotted at Rs. 134 per share on conversion of warrants.
  • Dr. Vajja Sambasiva Rao reappointed as Independent Director for a second five-year term.
  • Company approved incorporation of a wholly-owned subsidiary in Singapore.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Amount raised via preferential allotment
248,83,97,822/-
Equity shares allotted
1,85,70,133
Issue price per share
134/-
Pre-issue paid-up capital
26,39,92,553/-
Post-issue paid-up capital
28,25,62,686/-
🏢 How This Affects the Company
📈
Business Impact
The incorporation of a Singapore subsidiary indicates potential international expansion or operational streamlining for Suven Life Sciences.
💰
Financial Impact
The preferential allotment has increased the company's paid-up equity share capital by Rs. 248,83,97,822/-, strengthening its balance sheet.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders for the preferential allotment or subsidiary incorporation.
👤
Who Is Affected
All existing shareholders are affected by the dilution from the issuance of 1,85,70,133 new equity shares.
🔍
Management Signal
Management is actively seeking capital through preferential allotment and pursuing international growth via a new subsidiary.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Disclosure of Singapore WOS operational details and strategy.
Annual General Meeting for shareholder approval of director re-appointment.
Future financial results reflecting impact of capital infusion.
LOW RISK Standard preferential allotment and subsidiary incorporation processes with no immediate red flags in the filing.
💡 Investor Takeaway
Suven Life Sciences raised Rs. 248.83 Crore via preferential allotment at Rs. 134 per share, increasing paid-up capital to Rs. 28,25,62,686/-.
⚖️ Strengths & Concerns

✅ Positives

  • Raised Rs. 248,83,97,822/- through preferential allotment of 1,85,70,133 equity shares.
  • Secured 100% consideration totaling Rs. 248,83,97,822/- for the preferential allotment.
📅 Company Track Record
Suven Life Sciences previously raised Rs. 2,71,970 via ESOP allotment in June 2026 and Rs. 248.83 Crore via preferential allotment earlier in July 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How much did Suven Life Sciences raise from the preferential allotment?
Suven Life Sciences raised Rs. 248,83,97,822/- by allotting 1,85,70,133 equity shares.
What was the issue price per share for the preferential allotment?
The issue price per share was Rs. 134/- for the preferential allotment.
What is the new paid-up equity share capital of Suven Life Sciences?
The post-issue subscribed & paid-up capital of Suven Life Sciences is Rs. 28,25,62,686/-.
What other key decisions were made by the Suven Life Sciences board?
The board approved re-appointment of an independent director and the incorporation of a wholly-owned subsidiary in Singapore.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.